Inflammatory bowel disease market size, share, trends, forecast 2018-2023


Posted June 17, 2019 by lisadavis

According to OMR analysis, the global inflammatory bowel disease market is estimated to grow at a significant CAGR during the forecast 2018-2023

 
According to OMR analysis, the global inflammatory bowel disease market is estimated to grow at a significant CAGR during the forecast period (2018-2023).The sedentary lifestyle and unhealthy food intake are one of the major causes behind the growth of the market. The prevalence of Crohn’s disease and Ulcerative colitis across the world has grown substantially, according to world IBD day a total of 10 million people lives with the disease. The substantial increase in the number of patients has also contributed significantly tothe growth of the market. The increased public and private investment in healthcare are propelling the growth in emerging economies.
A full report of global inflammatory bowel disease marketis available at https://www.omrglobal.com/industry-reports/inflammatory-bowel-disease-market/
Furthermore, the global inflammatory bowel disease market is segmented on the basis of disease type, diagnosis method, and treatment approach. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.
Market Segmentation
1. Global IBDMarket by Disease Type
• Ulcerative Colitis
• Crohn’s Disease
2. Global IBD Market by Diagnosis Method
• Blood And Stool Tests
• Endoscopies
• Ultrasound
• X-Rays
3. Global IBDMarket by Treatment Approach
• Surgery
• Anti- Inflammatory Drug Administration

Region Covered

• North America (the US and Canada)
• Europe (United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the Word (the Middle East & Africa and Latin America)

Company Profiled

• Accesa Labs, Inc.
• Amag Pharmaceuticals
• American Regent, Inc.
• CSC Pharmaceuticals
• Daiichi Sankyo
• Emisphere Technologies, Inc.
• Empower Pharmacy
• Endo Pharmaceuticals, Inc.
• Galenica
• Glaxosmithkline
• Laboratory Corporation Of America
• Mercator Pharma
• Panacea Biotec, Ltd.
• Pharmacosmos
• Rpg Life Sciences, Ltd.
• Sanofi
• Takeda Pharmaceutical Co., Ltd.
For related reports please visit: https://www.omrglobal.com/reports-category/healthcare/
About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, company profiling, consulting and other research-based services. OMR provides global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provides a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendation, and detailed company profiles.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Lisa Davis
Country India
Categories Business
Tags inflammatory bowel disease market
Last Updated June 17, 2019